X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs DR. DATSONS LABS - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. DR. DATSONS LABS WOCKHARDT LTD./
DR. DATSONS LABS
 
P/E (TTM) x -20.7 -10.9 - View Chart
P/BV x 2.2 0.2 1,350.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT LTD.   DR. DATSONS LABS
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-18
DR. DATSONS LABS
Mar-14
WOCKHARDT LTD./
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,012126 805.7%   
Low Rs53231 1,720.1%   
Sales per share (Unadj.) Rs355.9133.0 267.6%  
Earnings per share (Unadj.) Rs-60.30.2 -39,758.0%  
Cash flow per share (Unadj.) Rs-46.86.6 -707.7%  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.8128.8 200.2%  
Shares outstanding (eoy) m110.6331.66 349.4%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x2.20.6 368.6%   
Avg P/E ratio x-12.8516.1 -2.5%  
P/CF ratio (eoy) x-16.511.8 -139.4%  
Price / Book Value ratio x3.00.6 492.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3792,477 3,446.3%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,37156 16,733.2%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,3694,211 935.0%  
Other income Rs m1,20279 1,527.7%   
Total revenues Rs m40,5714,289 945.9%   
Gross profit Rs m18569 3.2%  
Depreciation Rs m1,495204 731.6%   
Interest Rs m2,555430 593.9%   
Profit before tax Rs m-2,83013 -22,280.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2576 4,213.1%   
Profit after tax Rs m-6,6695 -138,927.1%  
Gross profit margin %013.5 0.3%  
Effective tax rate %-9.148.0 -18.9%   
Net profit margin %-16.90.1 -14,858.2%  
BALANCE SHEET DATA
Current assets Rs m33,7966,852 493.3%   
Current liabilities Rs m26,9176,711 401.1%   
Net working cap to sales %17.53.3 521.8%  
Current ratio x1.31.0 123.0%  
Inventory Days Days79161 49.3%  
Debtors Days Days89318 28.0%  
Net fixed assets Rs m39,6643,673 1,079.9%   
Share capital Rs m553317 174.7%   
"Free" reserves Rs m27,9683,761 743.6%   
Net worth Rs m28,5224,078 699.5%   
Long term debt Rs m21,7311,671 1,300.6%   
Total assets Rs m81,62012,633 646.1%  
Interest coverage x-0.11.0 -10.4%   
Debt to equity ratio x0.80.4 185.9%  
Sales to assets ratio x0.50.3 144.7%   
Return on assets %-5.03.4 -146.4%  
Return on equity %-23.40.1 -19,861.3%  
Return on capital %-7.77.7 -100.0%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m9,807964 1,017.3%   
Fx outflow Rs m1,789607 294.6%   
Net fx Rs m8,019357 2,246.7%   
CASH FLOW
From Operations Rs m6841,345 50.9%  
From Investments Rs m6,302-2,256 -279.4%  
From Financial Activity Rs m-7,695-1,200 641.3%  
Net Cashflow Rs m-664-2,111 31.5%  

Share Holding

Indian Promoters % 74.5 4.5 1,644.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.0 -  
FIIs % 7.7 1.4 570.4%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 94.1 16.4%  
Shareholders   67,757 20,807 325.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   AJANTA PHARMA  FDC LTD.  SUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red, Global Markets Cautious, and Top Stocks in Action(Pre-Open)

On Monday, share markets in India opened on a positive note and ended the day in red after a volatile day of trading.

Related Views on News

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Nov 12, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS